Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans (Q33907331)

29 July 2017

0 references

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans (English)

1 reference

29 July 2017

1 reference

Liechti ME

1

1 reference

PubMed ID

10871712

29 July 2017

Vollenweider FX

series ordinal

2

1 reference

PubMed ID

10871712

29 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

European Neuropsychopharmacology

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

4

1 reference

29 July 2017

289-295

1 reference

Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Pharmacokinetics of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Effects of intravenous cocaine are partially attenuated by haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900086-9

7 January 2021

10.1016/S0924-977X(00)00086-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10871712